[New reversing agents that target membrane transporters].
Akiyama
Shin-ichi
S
Department of Molecular Oncology, Graduate School of Medical and Dental Sciences, Kagoshima University.
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000096:biosynthesis; D018528:ATP-Binding Cassette Transporters / Q000737:chemistry; D000970:Antineoplastic Agents / Q000494:pharmacology; D001549:Benzamides; D018432:Drug Resistance, Multiple; D019008:Drug Resistance, Neoplasm; D006801:Humans; D000068877:Imatinib Mesylate; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism*; D010879:Piperazines / Q000494:pharmacology; D011743:Pyrimidines / Q000494:pharmacology
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D018528:ATP-Binding Cassette Transporters; D000970:Antineoplastic Agents; D001549:Benzamides; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate